FRIDAY MARCH 24, 2023 | HALL A | |
07:30–08:30 | Iveric Bio Pre-Congress Industry Sponsored Breakfast Symposium: Are You Ready for the Future? Treating Geographic Atrophy with Complement Modulation-Based Therapies |
Faculty: | Peter K. Kaiser, USA, Baruch D. Kuppermann, USA, Anat Loewenstein, Israel |
07:30 | Introduction-pre test |
07:35 | Prevalence, Unmet Need, Impact on Quality of Life |
07:40 | Imaging Modalities for Assessing Atrophy |
07:50 | The atrophy is in the details |
08:00 | A discovery of lesions |
08:10 | A new era of GA treatments – targeting complement system modulation |
08:20 | Patient education and setting expectations |
08:25 | Closing remarks – post-test |
12:15–13:15 | Roche Industry Sponsored Luncheon Symposium: Advancing the management of nAMD via Ang-2/VEGF-A dual inhibition (Lunch boxes served 12:00–12:15) |
Chair: | Ângela Carneiro, Portugal |
12:15 | Welcome and opening remarks Ângela Carneiro, Portugal |
12:20 | Evidence for Ang-2/VEGF-A inhibition in nAMD: Preclinical and Phase 3 data Rufino Silva, Portugal |
12:35 | Real-world clincial case discussions James Talks, UK David Almeida, USA Audience Q&A with the panel |
13:10 | Closing remarks Ângela Carneiro, Portugal |
16:15–17:15 | Roche Industry Sponsored Symposium: Advancing the management of DME via Ang-2/VEGF-A dual inhibition |
Chair: | João Figuera, Portugal |
16:15 | Welcome and opening remarks João Figuera, Portugal |
16:20 | Evidence for Ang-2/VEGF-A inhibition in DME: Preclinical and Phase 3 data Sara Vaz-Pereira, Portugal |
16:35 | Real-world clinical case discussions Sobha Sivaprasad, UK David Almeida, USA Audience Q&A with the panel |
17:10 | Closing remarks João Figuera, Portugal |
SATURDAY MARCH 25, 2023 | HALL A | |
12:15–13:15 | Abbvie Industry Sponsored Luncheon Symposium: Detailed program to be uploaded shortly (Lunch boxes served 12:00–12:15) |
13:30–14:30 | Bayer Industry Sponsored Symposium Detailed program to be uploaded shortly (Dessert boxes served 13:15–13:30) |